prr director transactions reveals nice earners

from an An artcle in today's Sydney Morning Herald.

"Things go quiet before the storm of reporting season "
July 23, 2011

"Scrutiny of Prima BioMed director transactions reveals nice earners."

... " Meanwhile, two directors of Prima BioMed - which is trying to develop what chairman Lucy Turnbull says is the world's first therapy vaccine to treat ovarian cancer - did some mighty profitable option exercising and selling.

CEO Martin Rogers exercised 12.3 million options at 2? apiece and sold 2.4 million shares at about 29? each. Non-executive director Richard Hammel exercised 7.6 million options at 2? and sold 2.4 million shares at about 29? each. "

.... I did mention this week that this was a 'cash in ' and profit taking .... cashing in on option entitlements ..... still will be interested to see if anything happens soon .... in relation to the timing of this sale ...

..... options were not due to expire until end of 2011 ...

..... so if the share price is about to rise ... why sell now ?

... or if the share price is about to go down ... why sell now ?

... do they know something ?

....they are entitled to do whatever they want of course .... as share options are part of their renumeration ..... just posing the question ... for the record

link to the article
http://www.smh.com.au/business/things-go-quiet-before-the-storm-of-reporting-season-20110722-1hszn.html